Research Interest 1
Julian's laboratory focuses on elucidating how respiratory viruses and Ebola hemorrhagic fever virus interact with the host cell. The laboratory uses a combination of high throughput proteomics and functional assays to identify host cell proteins that are essential for virus biology. The idea being that these proteins would represent novel targets for transient anti-viral therapy. The main viruses understudy include those important for global health and food security. This includes a Medical Research Council (MRC) funded project on human respiratory syncytial virus and influenza A virus and funding from Public Health England to support research on emerging and hemorrhagic fever viruses. He works closely with Dr. John Barr at the University of Leeds Prof. Paul Digard at the Roslin Institute and Dr. David Matthews at the University of Bristol.
- EVIDENT - High throughput analysis of samples from the West African ebola outbreak
- Health Protection Research Unit: Emerging Infections (including zoonoses) and Biological Threats.
- EMBO Workshop on Integrating omic approaches to host pathogen interactions
- Analysis of the function of infectious bronchitis virus accessory proteins - towards better vaccines
- Zana Mahmood - bench fees
- Waleed Al Jabr bench fees
- Predicting Influenza severity by proteomics (PrInSeP).
- The role of cellular RNA editing in human respiratory syncytial virus and influenza virus biology.
Dr. Roger Hewson and Prof. Miles Carroll
External: Health Protection Agency
Collaborate on emerging viral pathogens
Prof. Paul Digard
External: University of Edinburgh
Collaborate on an MRC funded project looking at the interaction of human respiratory syncytial virus and influenza A virus with the host.
Dr. John N. Barr
External: University of Leeds
Investigating respiratory and emerging pathogens on joint MRC and Health Protection Agency funded projects.